• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系列:实用试验与真实世界证据:论文3. 患者选择的挑战与后果

Series: Pragmatic trials and real world evidence: Paper 3. Patient selection challenges and consequences.

作者信息

Oude Rengerink Katrien, Kalkman Shona, Collier Susan, Ciaglia Antonio, Worsley Sally D, Lightbourne Alison, Eckert Laurent, Groenwold Rolf H H, Grobbee Diederick E, Irving Elaine A

机构信息

Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Universiteitsweg 100, Utrecht 3584 CG, The Netherlands.

Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Universiteitsweg 100, Utrecht 3584 CG, The Netherlands.

出版信息

J Clin Epidemiol. 2017 Sep;89:173-180. doi: 10.1016/j.jclinepi.2016.12.021. Epub 2017 May 11.

DOI:10.1016/j.jclinepi.2016.12.021
PMID:28502808
Abstract

This paper addresses challenges of identifying, enrolling, and retaining participants in a trial conducted within a routine care setting. All patients who are potential candidates for the treatments in routine clinical practice should be considered eligible for a pragmatic trial. To ensure generalizability, the recruited sample should have a similar distribution of the treatment effect modifiers as the target population. In practice, this can be best achieved by including-within the selected sites-all patients without further selection. If relevant heterogeneity between subgroups is expected, increasing the relative proportion of the subgroup of patients in the heterogeneous trial could be considered (oversampling) or a separate trial in this subgroup can be planned. Selection will nevertheless occur. Low enrollment and loss to follow-up can introduce selection and can jeopardize validity as well as generalizability. Pragmatic trials are conducted in clinical practice rather than in a dedicated research setting, which could reduce recruitment rates. However, if a trial poses a minimal burden to the physician and the patient and routine clinical practice is maximally adhered to, the participation rate may be high and loss to follow-up will not be a specific problem for pragmatic trials.

摘要

本文探讨了在常规护理环境中进行试验时,识别、招募和留住参与者所面临的挑战。在常规临床实践中,所有可能接受治疗的患者都应被视为符合实用试验的条件。为确保普遍性,招募的样本应具有与目标人群相似的治疗效果修饰因素分布。在实践中,最好的方法是在选定的地点纳入所有患者,无需进一步筛选。如果预期亚组之间存在相关异质性,可以考虑增加异质性试验中患者亚组的相对比例(过度抽样),或者可以计划在该亚组中进行单独试验。然而,选择仍会发生。低招募率和失访会引入选择偏倚,并可能危及有效性和普遍性。实用试验是在临床实践中进行的,而不是在专门的研究环境中,这可能会降低招募率。然而,如果试验给医生和患者带来的负担最小,并且最大程度地遵循常规临床实践,参与率可能会很高,失访对于实用试验来说也不会是一个特殊问题。

相似文献

1
Series: Pragmatic trials and real world evidence: Paper 3. Patient selection challenges and consequences.系列:实用试验与真实世界证据:论文3. 患者选择的挑战与后果
J Clin Epidemiol. 2017 Sep;89:173-180. doi: 10.1016/j.jclinepi.2016.12.021. Epub 2017 May 11.
2
Series: Pragmatic trials and real world evidence: Paper 8. Data collection and management.系列:实用临床试验和真实世界证据:第 8 篇论文。数据收集和管理。
J Clin Epidemiol. 2017 Nov;91:13-22. doi: 10.1016/j.jclinepi.2017.07.003. Epub 2017 Jul 14.
3
Series: Pragmatic trials and real world evidence: Paper 2. Setting, sites, and investigator selection.系列:实用试验与真实世界证据:论文2. 研究背景、研究地点及研究者选择
J Clin Epidemiol. 2017 Aug;88:14-20. doi: 10.1016/j.jclinepi.2017.05.003. Epub 2017 May 11.
4
Series: Pragmatic trials and real world evidence: Paper 7. Safety, quality and monitoring.系列文章:实用临床试验和真实世界证据:第 7 篇。安全性、质量和监测。
J Clin Epidemiol. 2017 Nov;91:6-12. doi: 10.1016/j.jclinepi.2017.05.004. Epub 2017 May 11.
5
Series: Pragmatic trials and real world evidence: Paper 6. Outcome measures in the real world.系列:实用试验与真实世界证据:论文6. 真实世界中的结局指标
J Clin Epidemiol. 2017 Oct;90:99-107. doi: 10.1016/j.jclinepi.2016.12.022. Epub 2017 May 11.
6
Pragmatic study designs for older adults with cancer: Report from the U13 conference.老年癌症患者实用研究设计:U13 会议报告。
J Geriatr Oncol. 2016 Jul;7(4):234-41. doi: 10.1016/j.jgo.2016.02.005. Epub 2016 Jul 5.
7
Series: Pragmatic trials and real world evidence: Paper 1. Introduction.系列:实用试验与真实世界证据:论文1. 引言。
J Clin Epidemiol. 2017 Aug;88:7-13. doi: 10.1016/j.jclinepi.2016.12.023. Epub 2017 May 24.
8
Series: Pragmatic trials and real world evidence: Paper 4. Informed consent.系列:实用试验与真实世界证据:论文4. 知情同意
J Clin Epidemiol. 2017 Sep;89:181-187. doi: 10.1016/j.jclinepi.2017.03.019. Epub 2017 May 11.
9
Willingness to participate in pragmatic dialysis trials: the importance of physician decisional autonomy and consent approach.参与实用透析试验的意愿:医生决策自主权和同意方式的重要性。
Trials. 2017 Oct 11;18(1):474. doi: 10.1186/s13063-017-2217-8.
10
Pragmatism in practice: lessons learned during screening and enrollment for a randomised controlled trial in rural northern Ethiopia.实践中的实用主义:在埃塞俄比亚北部农村进行随机对照试验的筛选和入组过程中获得的经验教训。
BMC Med Res Methodol. 2018 Mar 7;18(1):26. doi: 10.1186/s12874-018-0486-x.

引用本文的文献

1
Motivation, barriers, and willingness to participate in clinical trials for novel cancer treatments among the Vietnamese population.越南人群参与新型癌症治疗临床试验的动机、障碍及意愿
PLoS One. 2025 Aug 29;20(8):e0331250. doi: 10.1371/journal.pone.0331250. eCollection 2025.
2
Diversity in decentralized clinical trials: prioritizing inclusion of underrepresented groups.分散式临床试验中的多样性:优先纳入代表性不足的群体。
BMC Med Ethics. 2025 Apr 24;26(1):51. doi: 10.1186/s12910-025-01211-7.
3
A Pilot Study to Evaluate the Feasibility and Acceptability of a Tailored Multicomponent Rehabilitation Program for Adolescent and Young Adult (AYA) Cancer Survivors.
一项评估针对青少年和青年癌症幸存者的定制多组分康复计划的可行性和可接受性的试点研究。
Cancers (Basel). 2025 Mar 22;17(7):1066. doi: 10.3390/cancers17071066.
4
Comparative Effectiveness of Active and Reactive Mattresses in Pressure Injury Healing for Older People in Their Own Homes: A Pragmatic Equivalence Randomised-Controlled Study.主动式和反应式床垫对居家老年人压力性损伤愈合的比较效果:一项实用等效性随机对照研究
Nurs Rep. 2025 Mar 19;15(3):111. doi: 10.3390/nursrep15030111.
5
Optimizing Recruitment and Retention in Cancer Clinical Trials in Low-Resource Settings: Barriers and Facilitators From Nigerian Provider's Perspectives.在资源匮乏地区优化癌症临床试验的招募与保留率:从尼日利亚医疗服务提供者视角看障碍与促进因素
JCO Glob Oncol. 2025 Feb;11:e2400308. doi: 10.1200/GO-24-00308. Epub 2025 Feb 13.
6
Large simple randomized controlled trials-from drugs to medical devices: lessons from recent experience.大型简单随机对照试验——从药物到医疗设备:近期经验教训
Trials. 2025 Jan 21;26(1):24. doi: 10.1186/s13063-025-08724-x.
7
Adapting self-measured blood pressure monitoring to reduce health disparities (ASPIRE): a pilot hybrid effectiveness‑implementation study protocol.调整自测血压监测以减少健康差距(ASPIRE):一项试点混合效果-实施研究方案
Pilot Feasibility Stud. 2025 Jan 15;11(1):7. doi: 10.1186/s40814-024-01588-z.
8
Promoting serious illness conversations in primary care through telehealth among persons living with cognitive impairment.通过远程医疗在认知障碍患者的初级保健中促进重病对话。
J Am Geriatr Soc. 2024 Oct;72(10):3022-3034. doi: 10.1111/jgs.19100. Epub 2024 Jul 23.
9
Design, Conduct, Analysis, and Reporting of Therapeutic Efficacy Studies in Visceral Leishmaniasis: A Systematic Review of Published Reports, 2000-2021.内脏利什曼病治疗疗效研究的设计、实施、分析和报告:2000-2021 年已发表报告的系统评价。
Am J Trop Med Hyg. 2024 Jul 2;111(2):365-376. doi: 10.4269/ajtmh.23-0458. Print 2024 Aug 7.
10
Statistical Considerations for the Design and Analysis of Pragmatic Trials in Aging Research.衰老研究中实用性试验设计与分析的统计学考量
Geriatrics (Basel). 2024 Jun 4;9(3):75. doi: 10.3390/geriatrics9030075.